Urgo Medical North America LLC

Urgo Medical North America is the North American subsidiary of the French family-owned Urgo Group, specializing in wound care and skin management products for hospitals, nursing homes, and home health agencies. The company's focused portfolio includes clinically proven devices and solutions for wound cleansing, debridement, and management across acute and chronic care settings. Vashe® Wound Solution, their flagship product, is the #1 wound cleanser used in U.S. hospitals—a hypochlorous acid-preserved solution for intact and non-intact skin available in both professional and over-the-counter formulations. UrgoClean Ag is a charged-fiber dressing designed for continuous slough debridement. UrgoK2 provides a revolutionary dual compression system for consistent wound compression therapy. UrgoTul and UrgoTul Ag feature the TLC Restoring Matrix, a non-adherent contact layer that forms a lipidocolloid gel on wound surfaces. Drawtex® is a hydroconductive wound dressing with LevaFiber™ Technology that draws exudate away from the wound. VasheGel extends the Vashe product line. The company serves institutional and retail markets, with regulatory clearances appropriate for wound care consumables sold in the United States. Urgo Medical North America is headquartered in Fort Worth, Texas, and operates as part of a larger European medical device organization with established manufacturing and distribution capabilities.